SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Care-plan review) — Nikola Tesla

PatientNikola Tesla
Date of birth1980-07-10
IdentifiersMRN HR-NI009-SYN; SSN (made up) 000-09-7408
Document date2026-06-30
AuthorBranimir Kovač-Holt, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Twenty-four-week OCD treatment review. [S]

History of Present Illness

Mr. Tesla returns twelve weeks after the increase to sertraline 150 mg. At the nurse telephone check two weeks after the increase he reported mild sweating and no other side effects. He now has mild delayed ejaculation, which he finds acceptable, and has missed no doses. The Y-BOCS his therapist was to rate at about week eighteen was not done: that session was spent on an exposure at his laboratory and no rating was rescheduled. He has had eighteen ERP sessions and will finish the course next month. His rituals take about 45 minutes a day; he still counts steps on some walks but can stop. He eats three meals a day without calculating, sleeps about six hours, and has stopped working after midnight. He has had no suicidal thoughts. [S]

ElementDetail
Missed ratingTherapist's Y-BOCS at about week eighteen not done
SertralineMild sweating and delayed ejaculation; no missed doses
RitualsAbout 45 minutes a day
Nutrition and sleepThree meals a day; about six hours of sleep
SafetyNo suicidal thoughts
Y-BOCS13, down from 28

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight up 3.1 kg since intake; energy good
GenitourinaryPositiveMild delayed ejaculation on sertraline
IntegumentaryNegativeHands normal; mild sweating
PsychiatricNegativeObsessions infrequent and brief; mood good; no suicidal thoughts

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-01-13 to 2026-02-24completedS
Sertraline 100 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-02-24 to 2026-04-07completedS
Sertraline 50 mg oral tablet, three tablets (150 mg) by mouth each morningThree tablets by mouth each morningOral route2026-04-07activeS
White petrolatum ointment, apply to both hands after each wash and at bedtimeApply a thin layer to both hands after washing and at bedtimeTopical route2026-01-13activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-30Body height188cmS
2026-06-30Body weight66.9kgS
2026-06-30Body mass index (BMI) [Ratio]18.9kg/m2S
2026-06-30Systolic blood pressure116mm[Hg]S
2026-06-30Diastolic blood pressure72mm[Hg]S
2026-06-30Heart rate66/minS
2026-06-30Respiratory rate14/minS
2026-06-30Body temperature36.6CelS
2026-06-30Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-30Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-06-30Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
2026-06-30Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma412pg/mL232-1245 pg/mLNormalS
2026-06-30Albumin [Mass/volume] in Serum or Plasma4.2g/dL3.5-5 g/dLNormalS

Physical Exam

Vital signs recorded on 2026-06-30; see the Vital Signs section. [S]

SystemFinding
GeneralSlim, relaxed, and animated
Mental statusArticulate and humorous; mood "like a weight lifted"; affect full; good insight; no suicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Obsessive-compulsive disorder, severe (Y-BOCS 28), with good insight: contamination, symmetry, and number obsessions; washing, counting, repeating in threes, and calculating compulsions; synthetic modern diagnosis linked to his own accounts of counting and calculating rituals and aversionsactiveconfirmed F42.2S — Synthetic modern diagnosis. His rituals and aversions are documented in his own words (D); calling them obsessive-compulsive disorder is a retrospective interpretation (R), and no diagnosis was made in his lifetime.
Irritant contact dermatitis of both hands from washing them 40 to 60 times a dayresolvedconfirmed L24.9S — Synthetic consequence of washing compulsions.
Underweight (BMI 18.1) with about 4 kg weight loss over six months, from skipped meals and food-calculating ritualsresolvedconfirmed R63.6S — Synthetic nutritional consequence echoing his documented habit of calculating the volume of food before eating.
Insufficient sleep, four hours a night, from late work and night-time ritualsresolvedconfirmed Z72.820S — Synthetic sleep problem echoing his documented claims about very short sleep.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyY-BOCS severity score (recorded in the note; no LOINC code found)At baseline and about every 4 to 6 weeks during acute treatmentCompleted today13, down 54 percent from 28: response
SurveyInterim Y-BOCS between the twelve-week review and todayAt baseline and about every 4 to 6 weeks during acute treatmentDeferredNot done, a deviation from the protocol: the therapist's Y-BOCS planned at about week eighteen was not done because that session was used for an exposure and no rating was rescheduled, leaving twelve weeks without a severity score during the titration. No harm resulted judging by today's score and review: he responded and had no suicidal thoughts. Corrective action: the therapist now enters a Y-BOCS in the shared record every sixth session, and the clinic registry flags a missing score
SurveyPHQ-9 and GAD-7 for secondary depression and anxietyAt baseline and periodically while depressive or anxiety symptoms are presentCompleted todayPHQ-9 3 (item 9 scored 0); GAD-7 5
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9 when given)Every visit during acute treatmentCompleted todayNo suicidal thoughts, intent, plan, or behavior since the last visit; PHQ-9 item 9 scored 0. Protective factors stronger than at intake. Safety plan reviewed
Medication safetySertraline adherence and adverse effects (nausea, diarrhea, sleep, activation, sexual effects)Every visit and two weeks after each dose increaseCompleted todayNurse call two weeks after the increase: mild sweating only. Today mild delayed ejaculation, acceptable to him; no missed doses
Self-managementExposure and response prevention attendance and homeworkEvery visit during acute treatmentCompleted todayEighteen sessions; course ends next month; booster sessions planned
ExaminationWeight and BMIEvery visit while underweightCompleted today66.9 kg, BMI 18.9, up 3.1 kg since intake
LaboratoryAlbumin and vitamin B12 after dietary changeOnce, after about six months of better intakeCompleted todayAlbumin 4.2 g/dL; vitamin B12 412 pg/mL
Self-managementSleep diaryEvery visit during acute treatmentCompleted todayAbout six hours a night
Medication safetyAntipsychotic augmentation monitoring (weight, glucose, lipids, movement)Only if an antipsychotic is addedNot indicatedNo augmentation; responding to sertraline and ERP

Goal progress:

Guideline basis: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)

Follow-up: Preventive visit in October; OCD review in about three months. Next scheduled visit 2026-10-13: periodic adult preventive visit. [S]